Stressors, Stress, and Neuroendocrine Integration of the Adaptive Response: The 1997 Hans Selye Memorial Lecture

[1]  M. Palkovits,et al.  Decreased central and peripheral catecholaminergic activation in obese Zucker rats. , 1995, Endocrinology.

[2]  G. Kingsley,et al.  Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[3]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[4]  G. Chrousos,et al.  Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. , 1996, The Journal of clinical endocrinology and metabolism.

[5]  G. Chrousos,et al.  The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.

[6]  J. Richter,et al.  Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse: a preliminary model. , 1994, The American journal of medicine.

[7]  G. Chrousos,et al.  The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. , 1997, The Journal of clinical endocrinology and metabolism.

[8]  S. Paul,et al.  CSF corticotropin-releasing hormone in depressed patients and normal control subjects. , 1987, The American journal of psychiatry.

[9]  G. Chrousos,et al.  Psychopathology in patients with endogenous Cushing's syndrome: ‘atypical’ or melancholic features , 1995, Clinical endocrinology.

[10]  S. Kasper,et al.  Abnormal pituitary-adrenal responses to corticotropin-releasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications. , 1991, The Journal of clinical endocrinology and metabolism.

[11]  D. Papanicolaou,et al.  Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. , 1996, Proceedings of the Association of American Physicians.

[12]  G. Chrousos,et al.  Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. , 1994, Endocrine reviews.

[13]  G. Mauceri,et al.  Rat hypothalamic corticotropin-releasing hormone secretion is stimulated by interleukin-1 in an eicosanoid-dependent manner. , 1990, Pharmacological research.

[14]  G. Chrousos,et al.  Arachidonic acid metabolites modulate rat hypothalamic corticotropin-releasing hormone secretion in vitro. , 1989, Neuroendocrinology.

[15]  G. Chrousos,et al.  Introduction: The Concept of Stress and Its Historical Development , 1988 .

[16]  E. Bass,et al.  Clinical Characteristics of Women With a History of Childhood Abuse: Unhealed Wounds , 1997 .

[17]  G. Chrousos,et al.  Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. , 1993, The Journal of clinical endocrinology and metabolism.

[18]  G. Chrousos,et al.  Corticotropin-Releasing Hormone Stimulation Following Low-Dose Dexamethasone Administration: A New Test to Distinguish Cushing's Syndrome From Pseudo-Cushing's States , 1993 .

[19]  G. Chrousos,et al.  The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. , 1992, JAMA.

[20]  G. Chrousos,et al.  Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM. , 1996, Endocrine journal.

[21]  D. Boumpas,et al.  Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates , 1993, Annals of Internal Medicine.

[22]  A Luger,et al.  Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. , 1987, The New England journal of medicine.

[23]  G. Chrousos,et al.  Impairment of adrenocortical function associated with increased plasma tumor necrosis factor-alpha and interleukin-6 concentrations in African trypanosomiasis. , 1994, Neuroimmunomodulation.

[24]  J. Calabrese,et al.  Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. , 1986, The New England journal of medicine.

[25]  G. Chrousos.  The Future of Pediatric and Adolescent Endocrinology , 1997, Annals of the New York Academy of Sciences.

[26]  G. Chrousos,et al.  The role of corticotropin-releasing hormone in neuroendocrine-immune interactions , 1997, Molecular Psychiatry.

[27]  G. Chrousos,et al.  Differences in corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol before and after weight loss. , 1997, The Journal of clinical endocrinology and metabolism.

[28]  G. Chrousos,et al.  Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. , 1996, Endocrine reviews.

[29]  D. Swaab,et al.  Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. , 1994, Neuroendocrinology.

[30]  G. Chrousos,et al.  Rat hypothalamic corticotropin-releasing hormone secretion in vitro is stimulated by interleukin-1 in an eicosanoid-dependent manner. , 1990, Life sciences.

[31]  G. Chrousos,et al.  In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. , 1996, Endocrinology.

[32]  G. Chrousos,et al.  Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. , 1993, The Journal of clinical investigation.

[33]  G. Chrousos,et al.  The ovine corticotropin-releasing hormone-stimulation test in type I diabetic patients and controls: suggestion of mild chronic hypercortisolism. , 1993, Metabolism: clinical and experimental.

[34]  J. Csernansky,et al.  Hippocampal atrophy in recurrent major depression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Chrousos,et al.  Syndromes of Glucocorticoid Resistance , 1993, Annals of Internal Medicine.

[36]  G. Chrousos,et al.  Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. , 1995, Endocrinology.

[37]  F. Goodwin,et al.  Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) , 1988, The New England journal of medicine.

[38]  J. Calabrese,et al.  Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. , 1991, The Journal of clinical endocrinology and metabolism.

[39]  P. Munson,et al.  The maternal hypothalamic–pituitary–adrenal axis in the third trimester of human pregnancy , 1996, Clinical endocrinology.

[40]  G. Chrousos,et al.  Interaction of epidermal growth factor with the hypothalamic-pituitary-adrenal axis: potential physiologic relevance. , 1988, The Journal of clinical endocrinology and metabolism.

[41]  G. Chrousos,et al.  Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. , 1994, The Journal of clinical endocrinology and metabolism.

[42]  G. Chrousos,et al.  Bone mineral density in women with depression. , 1996, The New England journal of medicine.

[43]  C. Mantzoros,et al.  Human leptin levels are pulsatile and inversely related to pituitary–ardenal function , 1997, Nature Medicine.

[44]  D. Papanicolaou,et al.  The Pathophysiologic Roles of Interleukin-6 in Human Disease , 1998, Annals of Internal Medicine.

[45]  A. Baum,et al.  Sex differences in sensitivity of the hypothalamic-pituitary-adrenal axis. , 1993 .

[46]  M. Demitrack,et al.  Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. , 1991, The Journal of clinical endocrinology and metabolism.

[47]  D. Papanicolaou,et al.  Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. , 1997, Neuroendocrinology.

[48]  M. Merino,et al.  Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries. , 1994, The Journal of clinical endocrinology and metabolism.

[49]  G. Chrousos,et al.  Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. , 1994, The Journal of clinical endocrinology and metabolism.

[50]  S. Pillemer,et al.  Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. , 1994, Arthritis and rheumatism.

[51]  G. Chrousos,et al.  Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. , 1997, The Journal of clinical endocrinology and metabolism.